Prescribing antidepressants to pregnant women: what is a family physician to do?
作者信息
Einarson Adrienne, Koren Gideon
机构信息
Motherisk Program, Hospital for Sick Children, 555 University Ave, Toronto, ON M5G 1X8.
出版信息
Can Fam Physician. 2007 Sep;53(9):1412-4, 1423-5.
Abstract
摘要
相似文献
1
Prescribing antidepressants to pregnant women: what is a family physician to do?
Can Fam Physician. 2007 Sep;53(9):1412-4, 1423-5.
2
Depression in pregnancy: risks to mother...and to her baby: neonatal abstinence syndrome...and serious respiratory problems.
Child Health Alert. 2006 Mar;24:3-4.
3
The use of antidepressants in pregnant and breastfeeding women: a review of recent studies.
J Hum Lact. 2010 May;26(2):187-95. doi: 10.1177/0890334409342071.
4
Fact: antidepressants and anxiolytics are not safe during pregnancy.
Eur J Obstet Gynecol Reprod Biol. 2007 Dec;135(2):145-8. doi: 10.1016/j.ejogrb.2007.06.010. Epub 2007 Jul 26.
5
Depression and pregnancy.
Compr Ther. 2009 Spring;35(1):44-9.
6
Antidepressant use during pregnancy: the benefit-risk ratio.
Am J Obstet Gynecol. 2012 Sep;207(3):157-63. doi: 10.1016/j.ajog.2012.02.009. Epub 2012 Feb 21.
7
Developmental outcomes of children exposed to antidepressants in pregnancy.
Aust N Z J Psychiatry. 2011 May;45(5):393-9. doi: 10.3109/00048674.2010.549995. Epub 2011 Feb 11.
8
[Are antidepressants a risk for the fetus?].
MMW Fortschr Med. 2015 Jan 19;157(1):30.
9
[Treatment of pregnant women with depression: continuing need for a professional debate].
Ugeskr Laeger. 2011 Aug 15;173(33):1988.
10
The risks associated with prenatal antidepressant exposure: time for a precision medicine approach.
Expert Opin Drug Saf. 2017 Aug;16(8):915-921. doi: 10.1080/14740338.2017.1341872. Epub 2017 Jun 23.
引用本文的文献
1
Prenatal antidepressant exposure: clinical and preclinical findings.
Pharmacol Rev. 2014 Feb 24;66(2):435-65. doi: 10.1124/pr.111.005207. Print 2014.
2
Reproductive hormone sensitivity and risk for depression across the female life cycle: a continuum of vulnerability?
J Psychiatry Neurosci. 2008 Jul;33(4):331-43.
本文引用的文献
1
Paroxetine and congenital malformations: meta-Analysis and consideration of potential confounding factors.
Clin Ther. 2007 May;29(5):918-926. doi: 10.1016/j.clinthera.2007.05.003.
2
Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects.
N Engl J Med. 2007 Jun 28;356(26):2684-92. doi: 10.1056/NEJMoa066584.
3
First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects.
N Engl J Med. 2007 Jun 28;356(26):2675-83. doi: 10.1056/NEJMoa067407.
4
Maternal use of selective serotonin reuptake inhibitors and risk of congenital malformations.
Epidemiology. 2006 Nov;17(6):701-4. doi: 10.1097/01.ede.0000239581.76793.ae.
5
Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data.
Arch Gen Psychiatry. 2006 Aug;63(8):898-906. doi: 10.1001/archpsyc.63.8.898.
6
Rates and predictors of depression treatment among pregnant women in hospital-affiliated obstetrics practices.
Gen Hosp Psychiatry. 2006 Jul-Aug;28(4):289-95. doi: 10.1016/j.genhosppsych.2006.04.002.
7
Selective serotonin reuptake inhibitors and adverse pregnancy outcomes.
Am J Obstet Gynecol. 2006 Apr;194(4):961-6. doi: 10.1016/j.ajog.2006.02.019.
8
Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn.
N Engl J Med. 2006 Feb 9;354(6):579-87. doi: 10.1056/NEJMoa052744.
9
Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants.
Arch Pediatr Adolesc Med. 2006 Feb;160(2):173-6. doi: 10.1001/archpedi.160.2.173.
10
Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment.
JAMA. 2006 Feb 1;295(5):499-507. doi: 10.1001/jama.295.5.499.
Zotero 插件